In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ever.

The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea,

In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known as Tirzepatide, for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.